Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
暂无分享,去创建一个
F. Magri | A. Sernicola | T. Grieco | C. Chello | A. Rossi | G. Caro | M. Muscianese | S. Michelini | M. Di Fraia | M. Fortuna
[1] R. Trüeb,et al. What can the hair tell us about COVID‐19? , 2020, Experimental dermatology.
[2] B. McLellan,et al. Telogen effluvium: a sequela of COVID‐19 , 2020, International journal of dermatology.
[3] A. Offidani,et al. Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience , 2020, Dermatologic therapy.
[4] Daniel J. Gould,et al. Cutaneous Manifestations of COVID-19: An Evidence-Based Review , 2020, American Journal of Clinical Dermatology.
[5] D. Fernández-Nieto,et al. Acute telogen effluvium associated with SARS-CoV-2 infection. , 2020, Australian journal of general practice.
[6] K. Karthik,et al. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19 , 2020, Human vaccines & immunotherapeutics.
[7] C. Colak,et al. Evaluation of the effects of COVID‐19 pandemic on hair diseases through a web‐based questionnaire , 2020, Dermatologic therapy.
[8] H. Ulrich,et al. Dengue Fever, COVID‐19 (SARS‐CoV‐2), and Antibody‐Dependent Enhancement (ADE): A Perspective , 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[9] N. Rivetti,et al. Management of telogen effluvium during the COVID‐19 emergency: Psychological implications , 2020, Dermatologic therapy.
[10] Tsung-Hsien Chang,et al. Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells , 2018, Front. Cell. Infect. Microbiol..
[11] A. Wróbel,et al. Interleukin-4 induces apoptosis in cultured human follicular keratinocytes, but not in dermal papilla cells. , 2002, European journal of dermatology : EJD.
[12] C. Harmon,et al. Interleukin-1beta is differentially expressed by human dermal papilla cells in response to PKC activation and is a potent inhibitor of human hair follicle growth in organ culture. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[13] A. Tosti,et al. Telogen effluvium due to recombinant interferon alpha-2b. , 1992, Dermatology.
[14] F. Malkinson. PATHOLOGIC DYNAMICS OF HUMAN HAIR LOSS , 1961 .
[15] A. Kligman. Pathologic dynamics of human hair loss. I. Telogen effuvium. , 1961, Archives of dermatology.